MoneyWorks4Me

The revenue declined to Rs. 5145.40 millions for the quarter ended December 2024 as compared to Rs. 5382.10 millions during the corresponding quarter last year.Modest increase of 21.85% in the Net Profit was reported from. 316.20 millions to Rs. 385.30  millions.The company reported a good operating profit of 716.20 millions compared to 614.20 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 5145.40 5382.10 -4.40 15505.90 17073.80 -9.18 22669.10 24979.70 -9.25
Other Income 113.70 16.80 576.79 118.60 30.70 286.32 41.80 22.30 87.44
PBIDT 716.20 614.20 16.61 1858.70 2001.40 -7.13 2703.10 2846.30 -5.03
Interest 75.70 67.50 12.15 222.00 220.70 0.59 301.60 325.30 -7.29
PBDT 640.50 546.70 17.16 1636.70 1780.70 -8.09 2401.50 2521.00 -4.74
Depreciation 120.20 118.00 1.86 355.90 353.30 0.74 476.70 472.90 0.80
PBT 520.30 428.70 21.37 1280.80 1427.40 -10.27 1924.80 2048.10 -6.02
TAX 135.00 112.50 20.00 322.50 370.00 -12.84 506.00 520.00 -2.69
Deferred Tax 15.00 5.00 200.00 40.00 25.00 60.00 10.00 -12.50 -180.00
PAT 385.30 316.20 21.85 958.30 1057.40 -9.37 1418.80 1528.10 -7.15
Equity 912.70 919.40 -0.73 919.40 926.00 -0.71 919.40 926.00 -0.71
PBIDTM(%) 13.92 11.41 21.97 11.99 11.72 2.26 11.92 11.39 4.65
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..